Hypersensitive Joint Reaction After Etanercept Treatment in a Patient with Juvenile Rheumatoid Arthritis

被引：2
作者：
Guo, Mindy Ming-Huey
Yang, Kuender D. [2 ]
Yu, Hong-Ren [1 ]
Kuo, Ho-Chang [1 ,3 ]
机构：
[1] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Pediat, Div Allergy Immunol & Rheumatol, Kaohsiung, Taiwan
[2] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Res Dept, Kaohsiung, Taiwan
[3] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan
来源：
JOURNAL OF RHEUMATOLOGY | 2011年 / 38卷 / 03期
关键词：
IDIOPATHIC ARTHRITIS; CHILDREN; SAFETY; EFFICACY; REGISTRY;
D O I：
10.3899/jrheum.100751
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：577 / 579
页数：3
相关论文
共 50 条
  • [21] Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients
    Southwood, Taunton R.
    Foster, Helen E.
    Davidson, Joyce E.
    Hyrich, Kimme L.
    Cotter, Catherine B.
    Wedderburn, Lucy R.
    Hull, Richard G.
    Venning, Helen E.
    Rahman, Joy K.
    Cummins, Carole L.
    RHEUMATOLOGY, 2011, 50 (01) : 189 - 195
  • [22] Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis
    Ge, Lanlan
    Gao, Yu
    Chen, Xin
    Guo, Jingxiao
    Zhang, Dongfeng
    Yang, Yanjun
    BMC PEDIATRICS, 2025, 25 (01)
  • [23] Probability of remission of juvenile idiopathic arthritis following treatment with steroid joint injection
    de Oliveira Sato, J.
    de Albuquerque Pedrosa Fernandes, T.
    Bicalho do Nascimento, C.
    Corrente, J. E.
    Saad-Magalhaes, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : 291 - 296
  • [24] Pneumocystis jirovecii pneumonia developed in a patient with rheumatoid arthritis after 14 weeks of iguratimod add-on to treatment with methotrexate and etanercept
    Arita, Yuki
    Taguchi, Hiroaki
    Kobayashi, Mari
    Tono, Toshihiro
    Ohsone, Yasuo
    Okano, Yutaka
    MODERN RHEUMATOLOGY, 2018, 28 (06) : 1041 - 1043
  • [25] Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes
    Su, Yueh
    Yang, Yao-Hsu
    Chiang, Bor-Luen
    CLINICAL RHEUMATOLOGY, 2017, 36 (09) : 1997 - 2004
  • [26] Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance
    Mori, Masaaki
    Sugiyama, Naonobu
    Morishima, Yosuke
    Sugiyama, Noriko
    Kokubo, Takeshi
    Takei, Syuji
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 101 - 107
  • [27] Meta-analysis of the Efficacy and Safety of Adalimumab, Etanercept, and Infliximab for the Treatment of Rheumatoid Arthritis
    Wiens, Astrid
    Venson, Rafael
    Correr, Cassyano J.
    Otuki, Michel Fleith
    Pontarolo, Roberto
    PHARMACOTHERAPY, 2010, 30 (04): : 339 - 353
  • [28] PREDICTORS OF RESPONSE TO ETANERCEPT TREATMENT DEPENDING ON JUVENILE IDIOPATHIC ARTHRITIS CATEGORY
    Kashchenko, E.
    Alexeeva, E.
    Bzarova, T.
    Valieva, S.
    Denisova, R.
    Lomakina, O.
    Isaeva, K.
    Soloshenko, M.
    Karaseva, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1387 - 1387
  • [29] Patient/rheumatologist evaluation of infusion treatment for rheumatoid arthritis
    Willeke, P.
    Becker, H.
    Wassenberg, S.
    Pavenstaedt, H.
    Jacobi, A. M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2011, 70 (03): : 232 - +
  • [30] Early Prediction of Clinical Response to Etanercept Treatment in Juvenile Idiopathic Arthritis Using Machine Learning
    Mo, Xiaolan
    Chen, Xiujuan
    Leong, Chifong
    Zhang, Song
    Li, Huiyi
    Li, Jiali
    Lin, Guohao
    Sun, Guangchao
    He, Fan
    He, Yanling
    Xie, Ying
    Zeng, Ping
    Chen, Yilu
    Liang, Huiying
    Zeng, Huasong
    FRONTIERS IN PHARMACOLOGY, 2020, 11
12345